Current data obtained mostly using the liquid formulation suggest that the tissue distribution of posaconazole is extensive, with a very large volume of distribution ( V ) owing to its high lipophilicity, which of itself typically means that critical illness-led PK changes may not be significant ( 13 ).
1
—
—